JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1649.453.45 (+0.21 %)
PREV CLOSE ( ) 1646.00
OPEN PRICE ( ) 1622.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4997
TODAY'S LOW / HIGH ( )1622.05 1690.00
52 WK LOW / HIGH ( )914.65 1935
NSE1650.407.5 (+0.46 %)
PREV CLOSE( ) 1642.90
OPEN PRICE ( ) 1651.15
BID PRICE (QTY) 1650.40 (545)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 147335
TODAY'S LOW / HIGH( ) 1643.45 1694.70
52 WK LOW / HIGH ( )875 1940
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 18-12 1976
Management Info
- Chairman - Managing Director
Registered Office

Address Neelam Centre, ' B 'wing,4th Floor ,Hind Cycle Road, Worli,
Mumbai,
Maharashtra-400030

Phone 022- 2482 2222

Email secretarialijftjbpharma.com

Website www.jbpharma.com

Registrars Details
Datamatics Business Solutions Ltd.
Plot No. B5,Part B Cross Lane,MIDC, Andheri (E),Mumbai
Listing : BSE, NSE, MCX
NEWS
05Feb Announcement under Regulation 30 (LOD
Allotment of Equity Shares on exercise of Stock options pursuant to Empl..
20Dec JB Chemicals & Pharmaceuticals trades
JB Chemicals & Pharmaceuticals is currently trading at Rs. 1472.90,..
19Dec JB Chemicals & Pharmaceuticals to exec
JB Chemicals & Pharmaceuticals has received approval for execution o..
30Nov J.B. Chemicals & Pharmaceuticals infor
J.B. Chemicals & Pharmaceuticals has informed that the Compensation..
13Nov J.B. Chemicals & Pharmaceuticals infor
Pursuant to Regulation 30 read with Schedule III and Regulation 46(2)(oa..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit1279.23888.9
Gross Profit 1764.1 5270.4
Operating Profit 22136733.4
Net Sales 800128841.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26946.00 (0.74%)
M.Cap (Rs. in Cr)57258.37
Sanofi India (BSE)
 8118.25 (2.06%)
M.Cap (Rs. in Cr)18696.83
Dr. Reddy's Lab (BSE)
 6155.15 (1.78%)
M.Cap (Rs. in Cr)102679.14
Divi's Lab (BSE)
 3436.75 (2.14%)
M.Cap (Rs. in Cr)91234.91
Glaxosmithkline Phar (BSE)
 1943.10 (3.26%)
M.Cap (Rs. in Cr)32917.29
Shareholding Pattern
PROMOTERS 53.83%
NON-INSTITUTION 17.28%
MUTUAL FUNDS/UTI 15.66%
FI/BANKS/INSURANCE 2.3%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.